SABI Mind Becomes First Clinic in Alberta to Offer Intravenous Ketamine Therapy
As the first non-hospital provider of IV ketamine therapy in Alberta, SABI Mind now offers an additional, more controlled option to help patients with mental health and chronic pain conditions.
FEBRUARY 19, 2025 [CALGARY, ALBERTA] — SABI Mind, a pioneering ketamine therapy clinic based in Calgary, is once again breaking new ground in the realm of treatment-resistant mental health and chronic pain. Known for innovative approaches and a commitment to client-centered care, SABI Mind has recently expanded its treatment options by offering intravenous (IV) ketamine therapy. As the first accredited out-of-hospital clinic in Alberta to offer this treatment, SABI Mind is advancing the province’s mental health care services by providing a precise and controllable option that allows the clinic to safely treat clients with more complex medical needs.
Building upon their existing expertise in intramuscular (IM) ketamine therapy, SABI Mind's introduction of IV ketamine therapy represents a significant step forward. IV ketamine therapy involves the administration of ketamine via intravenous infusion, allowing for a more direct and controlled delivery of the medication into the bloodstream. This method has gained global attention for its potential to provide rapid relief to individuals dealing with severe depression, anxiety, and related conditions.
“We can provide even greater access to therapy for patients with significantly less risk,” states Dr. Craig Pearce, Medical Director at SABI Mind. “With IV ketamine therapy, we can now intervene more effectively, providing rapid and targeted treatment for potentially suicidal patients in a way no other antidepressant can.”
Both IV and IM ketamine therapies offer significant advantages over other administration methods, such as intranasal or sublingual routes. IV and IM ketamine provide higher bioavailability and more consistent dosing, promoting greater reliability and treatment response. The addition of IV ketamine as an option allows for precise dosage control, making it particularly suitable for clients with more complex medical needs or those who require careful titration. Together, IV and IM ketamine treatments stand out for their rapid onset of action, often delivering noticeable improvements in mood and symptom reduction within hours to days—a stark contrast to traditional antidepressants, which can take weeks or months to show results, if at all. This swift and effective relief is especially significant for individuals in acute distress or those who have not responded to conventional treatments.
“Our mission at SABI Mind has always been to provide opportunities for better health, improved quality of life and the discovery of new wholeness,” said Heesoo Cho, co-founder of SABI Mind. “Our team is proud to introduce IV ketamine therapy to our treatment offerings and bring hope to Albertans who have experienced previous treatment failures.”
For more information and to learn more, please visit www.sabimind.com. Follow SABI Mind on Instagram: www.instagram.com/sabimind/, Facebook: www.facebook.com/SABIMIND and Twitter: https://twitter.com/SabiMind
About SABI Mind
Located in Calgary, SABI Mind supports the careful and necessary mending of mental health and chronic pain through a suite of medical and integrative services including ketamine treatment. Motivated to find innovative solutions for patients with mental health and chronic pain disorders, SABI Mind empowers those discouraged by the conventional medical methods with a patient-centered treatment model supported by experienced psychiatrists, anesthesiologists, therapists, client experience specialists, and other clinic staff specially trained in ketamine therapy.
Learn More Here.
